NCT02636322
- Conditions
- Diffuse Large B-Cell Lymphoma Unclassifiable
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Diffuse Large B-Cell Lymphoma Unclassifiable
Explore clinical trials studying Diffuse Large B-Cell Lymphoma Unclassifiable. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Diffuse Large B-Cell Lymphoma Unclassifiable trial results
Active, Not Recruiting
Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT04665765
- Conditions
- Diffuse Large B-Cell Lymphoma Unclassifiable, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Emory University Atlanta, Georgia, United States